Prev Arrow Stocks

Teladoc Health Inc. ($TDOC) Stock Forecast: Up 5.4% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Teladoc Health Inc.?

Teladoc Health (TDOC) is a leading telemedicine company that provides virtual healthcare services to patients worldwide. The company has been focusing on expanding its virtual care platform and improving efficiency to meet the growing demand for remote medical consultations.

Why is Teladoc Health Inc. going up?

TDOC stock is up 5.4% on Jun 29, 2026 18:01

  • Teladoc (TDOC) saw a strong increase in its stock price, rising by 6.1%.
  • The surge in trading volume and positive investor sentiment about the company's growth prospects and turnaround plan likely fueled this upward trend.
  • Despite anticipated challenges like an upcoming earnings report showing a projected loss per share and revenue decline, Teladoc's emphasis on expanding its virtual care platform and forming strategic partnerships, such as with Walmart Better Care Services, may be instilling confidence among investors.
  • Although there was some initial stock price volatility due to Teladoc's removal from various Russell Growth indexes, investors appear to be more focused on the company's long-term strategy of virtual care adoption and potential profitability.

TDOC Price Chart

TDOC Technical Analysis

TDOC News

Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last?

Teladoc (TDOC) shares recently gained 6.1% due to increased trading volume and investor optimism regarding the company's growth prospects and turnaround strategy. While the company is focusing on expanding its virtual care platform and improving efficiency, its upcoming earnings report is projected to show a loss per share and a decrease in revenue. The stock currently holds a Zacks Rank #3 (Hold), and its future strength depends on trends in earnings estimate revisions.

https://finance.yahoo.com/markets/stocks/articles/teladoc-tdoc-moves-6-1-155300345.html

0 News Article Image Teladoc (TDOC) Moves 6.1% Higher: Will This Strength Last?

Affiliate files Form 144 to sell 2,500 restricted shares (TDOC)

An affiliate of Teladoc Health (TDOC) has filed a Form 144 to sell 2,500 restricted shares that vested on June 1, 2025. The filing also indicates that 7,679 shares were sold in the prior three months for over $58,000. Fidelity Brokerage Services LLC is listed as the broker for the proposed resale.

https://www.stocktitan.net/sec-filings/TDOC/144-teladoc-health-inc-sec-filing-08a75378ea97.html

1 News Article Image Affiliate files Form 144 to sell 2,500 restricted shares (TDOC)

Teladoc Health (TDOC) Faces Broad Russell Index Exit Is Its Investment Narrative Being Rewritten?

Teladoc Health (TDOC) was recently removed from several Russell Growth indexes, including the Russell 2000 and 3000, which could lead to mechanical selling by index-linked funds and impact its institutional ownership. While this exit adds share price volatility, it doesn't alter Teladoc's core investment narrative centered on virtual care adoption and partnerships like Walmart Better Care Services. Investors are advised to consider the long-term implications of reimbursement and margin pressures on its path to profitability, as analysts have varying forecasts for its revenue and earnings.

https://simplywall.st/stocks/us/healthcare/nyse-tdoc/teladoc-health/news/teladoc-health-tdoc-faces-broad-russell-index-exit-is-its-in/amp

2 Missing News Article Image Teladoc Health (TDOC) Faces Broad Russell Index Exit Is Its Investment Narrative Being Rewritten?

Enterprise value to revenue forward of Teladoc Health, Inc. – NYSE:TDOC

The article presents financial data for Teladoc Health, Inc. (NYSE: TDOC), specifically focusing on its enterprise value to revenue forward metric. It appears to be a financial data point provided by TradingView, indicating a quantitative measure for the company over a specific period.

https://www.tradingview.com/symbols/NYSE-TDOC/financials-statistics-and-ratios/enterprise-value-sales-fwd/

3 News Article Image Enterprise value to revenue forward of Teladoc Health, Inc. – NYSE:TDOC

Price to sales forward of Teladoc Health, Inc. – NYSE:TDOC

This article provides financial information for Teladoc Health, Inc. (NYSE: TDOC), specifically focusing on its forward price-to-sales ratio. It details the company's ticker symbol on the New York Stock Exchange and touches upon various data sources and copyright information related to the financial data presented.

https://www.tradingview.com/symbols/NYSE-TDOC/financials-statistics-and-ratios/price-sales-fwd/

4 News Article Image Price to sales forward of Teladoc Health, Inc. – NYSE:TDOC

Teladoc Health Inc. Price History

29.05.2026 - TDOC Stock was up 5.4%

  • Teladoc (TDOC) saw a strong increase in its stock price, rising by 6.1%.
  • The surge in trading volume and positive investor sentiment about the company's growth prospects and turnaround plan likely fueled this upward trend.
  • Despite anticipated challenges like an upcoming earnings report showing a projected loss per share and revenue decline, Teladoc's emphasis on expanding its virtual care platform and forming strategic partnerships, such as with Walmart Better Care Services, may be instilling confidence among investors.
  • Although there was some initial stock price volatility due to Teladoc's removal from various Russell Growth indexes, investors appear to be more focused on the company's long-term strategy of virtual care adoption and potential profitability.

29.05.2026 - TDOC Stock was up 5.4%

  • The positive reputation gained by Dr. Ethan Berke, the Chief Medical Officer, as one of the "Most Influential Clinical Executives 2026" potentially influenced the bullish movement in TDOC stock today, boosting confidence among investors.
  • Strong financial metrics such as enterprise value to revenue forward and price to sales forward ratios may have signaled solid fundamentals and growth potential, fueling optimism among investors and contributing to the stock's upward momentum.
  • Financial actuals and estimates for TDOC stock, combined with analyst forecasts and technical analysis ratings, likely presented a favorable outlook on the company's financial health and future growth prospects, driving investor interest and pushing the stock price higher.

05.05.2026 - TDOC Stock was down 5.5%

  • Today, the bearish movement in TDOC stock is linked to significant insider selling, as Fernando Rodrigues, President of BetterHelp, divested all his shares in the company, possibly unsettling investors.
  • Recently, TDOC saw a 7.6% stock price increase following Walmart's expanded integration of Teladoc's virtual care services; however, this positive development was overshadowed by the insider sell-off.
  • The conflicting signals of insider selling and positive business news have caused uncertainty among investors, resulting in the bearish movement in TDOC stock today.
  • Analysts express cautious market sentiment towards TDOC, noting the company's undervaluation, growth potential, and challenges in profitability and margin improvement in certain business segments.

29.04.2026 - TDOC Stock was up 7.5%

  • The positive market response to the expanded partnership with Walmart has contributed to the bullish movement in TDOC stock today.
  • The collaboration with Walmart broadens Teladoc's consumer access and market reach, appealing to both insured and uninsured individuals.
  • Teladoc's strategic shift towards visit-based revenue models and new services on Walmart's platform demonstrate the company's proactive market expansion, driving stock price growth.
  • Investors should monitor the adoption and profitability of these new services as Teladoc aims to create long-term shareholder value through innovation and strategic partnerships.

02.05.2026 - TDOC Stock was down 5.1%

  • The bearish movement in Teladoc Health's stock today could be attributed to investors reassessing the company's valuation after its recent partnership with Walmart and mixed earnings reaction.
  • Despite the expansion of virtual care services through Walmart's platform, concerns about Teladoc's valuation being approximately 7% overvalued based on a narrative-based assessment and its 3-year total shareholder return remaining down by 68.91% may have contributed to the bearish market movement.
  • Investors are closely monitoring the adoption of the new services offered through the Walmart partnership and assessing Teladoc's profitability, especially as the company continues to report net losses, which could be influencing the negative sentiment towards the stock.
  • The broader market reaction to Teladoc Health's strategic moves and financial performance, coupled with the ongoing evaluation of its valuation metrics, likely played a role in today's bearish movement.

28.04.2026 - TDOC Stock was up 6.1%

  • TDOC stock saw a 7% surge after revealing its partnership with Walmart to provide virtual care services on the Better Care Services platform.
  • This collaboration with Walmart broadens TDOC's customer base, making healthcare more convenient and cost-effective.
  • Offering virtual urgent care, dermatology, and nutrition services at $89 on Walmart's platform likely fueled the positive movement in TDOC stock.
  • Through affiliations with reputable retailers such as Walmart, TDOC is strategically aligning itself to address the growing demand for accessible and convenient healthcare services, boosting market optimism and investor trust in the stock.

04.05.2026 - TDOC Stock was up 5.1%

  • The bullish movement in TDOC's stock price today could be attributed to insider trading activities within the company, where key executives have been exercising stock options and selling shares to cover tax obligations.
  • The increased buying activity by executives may have instilled confidence in investors about the company's future prospects.
  • Additionally, the news of Teladoc's virtual care integration with Walmart and the upgraded price targets from analysts could have further fueled positive sentiment around the stock, contributing to its bullish movement today.

18.05.2026 - TDOC Stock was up 5.2%

  • The bullish movement in TDOC stock today can be attributed to the positive impact of strategic partnerships, such as the one with Walmart, which have highlighted the company's growth potential.
  • Despite conflicting earnings signals and projections of a decline in earnings, analysts are optimistic about Teladoc's revenue growth potential, with estimates reaching $2.6 billion by 2029.
  • The CEO's recent stock transactions, while routine for tax obligations, may have also instilled confidence in investors regarding the company's leadership and future prospects.
  • The surge in Teladoc's stock price after being identified as undervalued by InvestingPro's Fair Value analysis, coupled with improved fundamentals, has likely attracted investors looking for growth opportunities in the telemedicine sector.

26.05.2026 - TDOC Stock was up 5.2%

  • Teladoc's stock price saw a 1.56% increase, surpassing the S&P 500's loss, and has risen notably by 16.69% over the past month.
  • Analysts forecast a decline in Q2 earnings per share and revenue for Teladoc, but they expect overall annual growth for the company.
  • The disclosure of Voss entities and Travis Cocke reporting beneficial ownership of 9.03 million shares in Teladoc Health likely bolstered positive market sentiment, showcasing confidence in the company's future prospects.
  • A Form 13G filing for Teladoc Health on June 22 may have sparked investor interest and contributed to the stock's bullish movement.

26.05.2026 - TDOC Stock was up 5.0%

  • Teladoc Health (TDOC) stock surged by 1.56%, surpassing the S&P 500's decline, and has shown a remarkable 16.69% increase over the past month.
  • Despite projections of a decrease in Q2 earnings per share and revenue, analysts foresee overall growth potential for the company.
  • The outperformance of TDOC amidst a falling market indicates investors' confidence in the telemedicine sector, especially during times of market volatility.
  • The Form 13G filing on June 22 may have also contributed to the positive sentiment surrounding Teladoc Health, potentially signaling increased institutional interest in the company.

03.05.2026 - TDOC Stock was down 5.9%

  • A recent Form 144 notice revealed a company insider's intention to sell 9,572 common shares, potentially indicating a lack of confidence in the stock's future performance and contributing to the bearish trend.
  • Despite expanding its virtual care services through collaborations with Walmart and joining Walmart's Better Care Services platform, Teladoc faced mixed reactions to its earnings and concerns over its valuation, impacting investor sentiment.
  • The company reported a decline in revenues and net losses in the first quarter of 2026, prompting scrutiny of its valuation and shareholder return, which may have further influenced the stock price negatively.
  • Investors are observantly tracking the uptake of new services introduced through the Walmart partnership and assessing Teladoc's trajectory towards profitability given its historical stock price fluctuations and financial results.

22.05.2026 - TDOC Stock was down 5.2%

  • Today's downward movement in TDOC may be influenced by the negative earnings projections and forecasts for revenue growth. The expected decline in EPS for the upcoming quarter and an average price target lower than the current value could be prompting investors to react to a more pessimistic outlook.
  • Despite a recent upswing, lingering memories of significant losses in 2022 and 2023 may still be affecting investor confidence, resulting in profit-taking and a bearish trajectory today.
  • The diverse opinions from analysts, with a majority recommending a "hold" on the stock, might be contributing to uncertainty about TDOC's future performance, causing some investors to divest their holdings.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.